ResearcherLund UniversityNo recent work listed

Mikael Segerlantz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5603-710X; OpenAlex author ID A5043057580. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

Integration of Specialized Palliative Care with Oncological Treatment in Patients with Advanced Pancreatic Cancer. Last author DOI 10.1089/pancan.2022.0004 ↗
Second-line palliative chemotherapy, survival, and prognostic factors in patients with advanced pancreatic cancer. Last author DOI 10.1080/0284186x.2021.1973680 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jakob Eberhard · 2 shared papers, 2021–2022 · strength 0.42
- Paper Integration of Specialized Palliative Care with Oncological Treatment in Patients with Advanced Pancreatic Cancer. DOI 10.1089/pancan.2022.0004 ↗
- Paper Second-line palliative chemotherapy, survival, and prognostic factors in patients with advanced pancreatic cancer. DOI 10.1080/0284186x.2021.1973680 ↗
Anders Ekström · 2 shared papers, 2021–2022 · strength 0.42
- Paper Integration of Specialized Palliative Care with Oncological Treatment in Patients with Advanced Pancreatic Cancer. DOI 10.1089/pancan.2022.0004 ↗
- Paper Second-line palliative chemotherapy, survival, and prognostic factors in patients with advanced pancreatic cancer. DOI 10.1080/0284186x.2021.1973680 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.